The Prevalence of Metabolic Syndrome and Associated Microvascular and Macrovascular Complication in Type 2 Diabetes Mellitus
Abstract
Askar Faiza, Bamashmoos Mohammed and Alaghbari Khaled
Methods: Across sectional study was carried out in AL Kuwait University Hospital consultation clinic in the period of June 2022 to May 2023. A total of 380 randomly selected adult patients with type 2-DM were included in the study. The diagnosis of diabetes was based on ADA criteria, while the diagnosis of MS was based on ATP 111 criteria. The patients were divided into two groups with and without metabolic syndrome (MS) and there clinical and laboratory parameters where studied and analyzed.
Results: About 308 (81%) of patients had MS according to ATP111 criteria female were equally affected as male. there was significant difference between patients with and without MS regarding central obesity, hypertension, low HDL and high LDL. Patients with MS had higher prevalence of retinopathy (29.2 % vs 16.6%), DSN || (23.3% vs 20.8%), DNP (40.5 VS 31.9%), coronary artery diseases (27.5% vs 16.6 %) and stroke (7.4 % vs 2.7%).
Conclusion: These data suggest MS in this population of Yemeni type – 2 diabetic patients is common and with estimated prevalence of 81% MS clearly poses a formidable health threat to Yemeni diabetic patients. Life style intervention in type 2 diabetic subjects are needed in Yemen to halt the burden of micro and macrovascular complication in type 2 DM Keywords; Metabolic Syndrome, Coronary Artery Diseases, Distal Sensory Neuropathy, Diabetic Nephropathy